查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1974091

人工智慧增強型磁振造影系統市場：按組件、磁振造影系統類型、應用和最終用戶分類－2026-2032年全球預測

AI-Enhanced MRI System Market by Component, MRI System Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，人工智慧增強型 MRI 系統市場價值將達到 102.7 億美元，到 2026 年將成長至 110 億美元，到 2032 年將達到 172.4 億美元，複合年成長率為 7.67%。

主要市場統計數據
基準年 2025 102.7億美元
預計年份：2026年 110億美元
預測年份 2032 172.4億美元
複合年成長率 (%) 7.67%

本次演講將清晰簡潔地介紹一個系統，該系統透過引入人工智慧增強磁振造影技術，將影像物理學、機器學習和臨床工作流程結合，重新定義了診斷效果和操作效率。

人工智慧增強型磁振造影（AI Enhanced MRI）融合了先進的影像物理學、機器學習和系統工程技術，正在革新臨床醫生獲取、解讀和應對診斷資訊的方式。深度學習驅動的重建、降噪和自動量化技術的創新，透過提高影像清晰度和縮短擷取時間，擴展了臨床工作流程，並為以患者為中心的通訊協定創造了新的機會。這些技術並非獨立運行，而是與資料管理平台、雲端運算服務和醫院資訊系統整合，從而實現模型最佳化、品質保證和結果追蹤的持續循環。

演算法的突破、硬體的小型化以及聯邦數據方法的進步，正在從根本上重塑 MRI 的功能、工作流程和醫療保健服務模式。

磁振造影（MRI）技術正經歷著變革性的轉變，這主要得益於演算法能力的提升、硬體的創新以及新型醫療服務模式的進步，這些因素共同重新定義了人們對影像品質、速度和臨床效用的期望。基於深度學習的重建技術能夠縮短採集時間，並實現低劑量或造影劑通訊協定，從而擴大了MRI診斷的適用人群。同時，磁鐵和梯度設計的改進正在降低系統面積和能耗，使得在傳統醫院環境之外部署MRI設備變得越來越可行。

本研究評估了美國在 2025 年實施的關稅措施對 MRI 供應鏈、籌資策略以及長期供應商和臨床夥伴關係的策略性連鎖反應。

美國將於2025年實施的新關稅措施，為依賴國際採購零件和子系統的供應商、系統整合商和醫療保健機構帶來了複雜的商業環境。關稅帶來的成本壓力正在影響籌資策略，促使相關人員尋求供應商多元化，考慮總到岸成本，並重新評估庫存政策。為此，製造商和系統整合商正在加快本地化進程，重組全球供應鏈，並探索替代零件採購管道，以維持價格穩定和交貨可靠性。

將組件架構、系統外形規格、臨床應用和最終用戶需求與策略性產品開發和商業化決策連結起來的綜合細分分析。

透過捕捉細微差異的細分分析，可以揭示不同組件、系統類型、應用和最終用戶之間獨特的技術和商業性動態，這些動態會影響產品設計、市場進入策略和臨床部署路徑。依組件分類，市場分析分為硬體、服務和軟體。硬體進一步細分為梯度系統和磁體系統；服務細分為安裝服務和維護服務；軟體細分為資料管理解決方案和影像軟體。這種組件層面的觀點突顯了研發投資趨勢，這些趨勢優先考慮的是提高磁鐵和梯度子系統的物理性能，或是開發支援下游臨床工作流程的雲端資料管理和演算法功能。

針對美洲、歐洲、中東、非洲和亞太地區的區域特定趨勢和戰略意義，探討其對採用、採購和夥伴關係策略的影響。

區域趨勢源自於基礎設施、報銷框架、管理體制和產業政策的差異，這些差異影響著人工智慧增強型磁振造影解決方案的採納路徑和競爭定位。在美洲，創新叢集和一體化醫療保健系統創造了有利於試點部署和企業級擴展先進成像應用的環境。臨床使用者往往優先考慮基於結果的證據和能夠提高臨床效率和診斷準確性的價值提案。因此，供應商通常會與學術機構和大型醫院網路合作，進行多中心臨床檢驗，以獲得臨床醫生的支援。

現有的 OEM 製造商、人工智慧創新者和系統整合商正在透過檢驗、夥伴關係和服務模式來脫穎而出，從而在不斷發展的 MRI 生態系統中建立競爭優勢。

人工智慧增強型磁振造影領域的競爭格局呈現出多元化的態勢，既有成熟的成像設備製造商，也有新興的人工智慧專家和系統整合商，各方都在技術研發和商業化方面發揮各自的優勢。現有設備製造商正利用其在磁鐵和梯度電路設計方面的深厚專業知識、全球服務網路以及現有的臨床關係，將人工智慧增強功能整合到下一代平台中。這些成熟企業往往專注於長期業務收益模式，旨在實現無縫整合、跨市場監管合規以及維護已部署設備的效能。

為技術開發人員、臨床領導者和採購團隊提供切實可行的策略建議，以加速人工智慧驅動的 MRI 創新技術的應用、管理風險並創造價值。

產業領導者應推動一系列合作舉措，將技術開發、臨床檢驗和商業化緊密結合，從而從人工智慧增強型磁振造影創新中創造價值。首先，應優先考慮模組化架構，將硬體升級與軟體/演算法改進分離，從而實現持續改進而無需迭代式資本投入。同時，應建立一套嚴謹的臨床評估流程，包括多中心合作研究和同行評審出版物，以增強臨床醫生的信心並獲得支付方的認可。

採用嚴謹的混合調查方法，結合臨床醫師訪談、監管分析、專利格局分析和證據三角驗證，指南策略決策，並找出證據不足的領域。

本研究整合了結構化調查方法所獲得的洞見，該方法結合了與臨床和技術相關人員的定性對話、對科學文獻和監管申請文件的系統性二手研究，以及透過技術和專利狀態分析進行的三角檢驗。主要研究包括對臨床醫生、放射科醫生、醫院採購負責人、系統整合商和研發經理的詳細訪談，以確定實際應用中的挑戰、臨床優先事項和採購考慮。基於這些對話，我們對用例進行了優先排序，並制定了檢驗演算法效能和服務預期所需的標準。

簡潔扼要的結論整合了成功大規模部署人工智慧驅動的 MRI 解決方案所需的基本技術、臨床和操作要求。

總而言之，人工智慧增強型磁振造影技術正從概念驗證計劃階段邁向整合臨床工具階段，從而改善診斷工作流程、提供量化支援並實現以患者為中心的成像通訊協定。重建技術、演算法分析和系統設計的技術進步正與不斷發展的醫療服務模式相融合，從而創造顯著的臨床和營運效益。同時，貿易政策、供應鏈重組和不斷變化的監管要求等結構性壓力也在影響解決方案的設計、採購和部署方式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：人工智慧增強型磁振造影系統市場：按組件分類

  • 硬體
    • 梯度系統
    • 磁性系統
  • 服務
    • 安裝服務
    • 維護服務
  • 軟體
    • 資料管理解決方案
    • 影像處理軟體

第9章：依MRI系統類型分類的AI增強型MRI系統市場

  • 封閉式磁振造影
  • 開放式磁振造影

第10章：人工智慧增強型磁振造影系統市場：按應用領域分類

  • 臨床試驗
  • 診斷影像
    • 心臟病學
    • 神經病學
    • 腫瘤學
  • 研究

第11章：人工智慧增強型磁振造影系統市場：依最終用戶分類

  • 診斷中心
  • 醫院
  • 私人執業放射科醫生
  • 研究機構

第12章：人工智慧增強型磁振造影系統市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：人工智慧增強型磁振造影系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：人工智慧增強型磁振造影系統市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國人工智慧增強型磁振造影系統市場

第16章：中國人工智慧增強型磁振造影系統市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Arterys Inc.
  • Blackford Analysis LTD
  • Canon Medical Systems Corporation
  • Cerebriu A/S
  • CityClinic Vietnam Limited
  • CureMetrix
  • EnvoyAI Inc.
  • Esaote SpA
  • Ezra AI, Inc.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • HeartVista, Inc.
  • Hitachi Medical Corporation
  • Hyperfine, Inc.
  • Koninklijke Philips NV,
  • Medic Vision Imaging Solutions
  • Neusoft Medical Systems
  • Nuance Communications
  • Perspectum Ltd
  • Samsung Electronics Co.Ltd
  • Siemens Healthineers AG
  • Subtle Medical, Inc.
  • United Imaging Healthcare Co., Ltd
  • Volpara Solutions
  • Zebra Medical Vision, Inc.
Product Code: MRR-5D340F440B73

The AI-Enhanced MRI System Market was valued at USD 10.27 billion in 2025 and is projected to grow to USD 11.00 billion in 2026, with a CAGR of 7.67%, reaching USD 17.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 10.27 billion
Estimated Year [2026] USD 11.00 billion
Forecast Year [2032] USD 17.24 billion
CAGR (%) 7.67%

A clear, concise introduction to how AI-enhanced MRI is converging imaging physics, machine learning, and clinical workflows to redefine diagnostic efficacy and operational efficiency

AI-enhanced MRI represents a convergence of advanced imaging physics, machine learning, and systems engineering that is reshaping how clinicians capture, interpret, and act on diagnostic information. Innovations in deep learning-powered reconstruction, noise reduction, and automated quantification are improving image clarity and shortening acquisition times, thereby expanding clinical workflows and creating new opportunities for patient-centric protocols. These technologies do not operate in isolation; they integrate with data management platforms, cloud compute services, and hospital information systems to enable a continuous cycle of model refinement, quality assurance, and outcome tracking.

Clinicians and health system leaders are increasingly motivated by the potential for AI to enhance diagnostic confidence, reduce repeat scans, and enable earlier interventions. At the same time, engineering teams focus on algorithm robustness, generalizability across scanner vendors, and compatibility with existing sequences and coils. Regulatory agencies have elevated expectations for clinical validation, traceability, and post-market surveillance, which in turn drives vendors to adopt rigorous evidence-generation processes. Consequently, successful adoption now requires cross-functional coordination among clinical champions, IT leaders, procurement, and vendor partners, who must all align on clinical use cases, deployment workflows, and measurable outcomes.

Looking forward, integration of AI into MRI workflows will prioritize patient throughput, reproducibility, and clinician interpretability. As a result, leaders who invest early in interoperable architectures, clinician training, and transparent model governance will be better positioned to translate technological promise into demonstrable clinical value. Transitional strategies that combine pilot implementations with iterative scale-up will reduce operational friction and accelerate the institutional learning necessary for broader adoption.

How algorithmic breakthroughs, hardware miniaturization, and federated data approaches are collectively reshaping MRI capabilities, workflows, and care delivery models

The landscape for MRI technology is undergoing transformative shifts driven by advances in algorithmic capability, hardware innovation, and new care delivery models that together redefine expectations for image quality, speed, and clinical utility. Deep learning-based reconstruction methods are shortening acquisition windows and enabling lower-dose or contrast-free protocols, which in turn expand the range of patient populations that can benefit from MRI diagnostics. Simultaneously, improvements in magnet and gradient designs are reducing system footprints and energy consumption, making deployment outside traditional hospital environments increasingly feasible.

Interoperability and data portability have become central as federated learning approaches emerge to train robust models across geographically dispersed datasets without exposing patient-level data. This shift toward distributed intelligence supports multi-center validation and reduces institutional bias, thereby improving clinical generalizability. Cloud-enabled orchestration is also changing how image processing and analytics are delivered: centralized compute resources enable rapid model updates, while edge-enabled inference preserves workflow speed and reduces latency in clinical settings.

Workforce transformation accompanies these technological changes. Radiologists and technologists are adopting decision support tools that highlight abnormalities, quantify tissue properties, and automate routine measurements, which frees time for complex interpretation and multidisciplinary collaboration. Consequently, service models are evolving to emphasize software maintenance, algorithm lifecycle management, and continuous clinical education. Partnerships between OEMs, AI specialists, and health systems are emerging as the dominant route to accelerate commercialization, with an emphasis on shared data assets, joint validation studies, and integrated go-to-clinic strategies.

Assessing the strategic ripple effects of United States tariff measures in 2025 on MRI supply chains, procurement strategies, and long-term vendor and clinical partnerships

The introduction of new tariff measures in the United States during 2025 is creating a complex operating environment for suppliers, integrators, and healthcare providers that rely on internationally sourced components and subsystems. Tariff-driven cost pressure has influenced procurement strategies, prompting stakeholders to re-evaluate supplier diversification, total landed cost considerations, and inventory policies. In response, manufacturers and system integrators are accelerating localization efforts, reconfiguring global supply chains, and considering alternative component sourcing to preserve pricing stability and delivery reliability.

These adjustments extend beyond hardware procurement to affect software licensing and service arrangements. Because many AI-enhanced MRI solutions combine hardware, embedded software, and cloud-based analytics, tariffs that target hardware components can have downstream implications for bundled service pricing and maintenance contracts. Organizations are therefore renegotiating long-term service agreements to account for evolving cost structures and to protect predictability in lifecycle spending. Moreover, regulatory timelines and customs processes have become more nuanced factors in vendor selection, as delays in customs clearance or import approvals can disrupt deployment schedules and clinical rollout plans.

To mitigate exposure, stakeholders are adopting strategic levers that include onshoring critical assembly tasks, establishing regional repair hubs to reduce cross-border movement of parts, and leveraging contractual mechanisms that share tariff risk across the supply chain. In parallel, alliances with local manufacturing partners and targeted investments in domestic capabilities help preserve continuity for clinical customers. These responses underline that tariffs are not merely a cost issue but a catalyst for longer-term structural changes in how MRI ecosystems are designed, produced, and supported.

Comprehensive segmentation insights that connect component architecture, system form factors, clinical applications, and end-user requirements to strategic product and commercialization decisions

A nuanced segmentation analysis reveals distinct technological and commercial dynamics across components, system types, applications, and end users that affect product design, go-to-market strategy, and clinical adoption pathways. Based on Component, the market is studied across Hardware, Services, and Software; the Hardware is further studied across Gradient Systems and Magnet Systems; the Services is further studied across Installation Services and Maintenance Services; the Software is further studied across Data Management Solutions and Imaging Software. This component-level view highlights how R&D investments prioritize either physical performance improvements for magnet and gradient subsystems, or cloud-enabled data management and algorithmic capabilities that deliver downstream clinical workflows.

Based on MRI System Type, the market is studied across Closed MRI and Open MRI, and each form factor presents distinct clinical and operational trade-offs. Closed systems continue to offer higher-field performance and advanced sequences suitable for complex neuro and oncologic imaging, whereas open systems address accessibility, patient comfort, and point-of-care scenarios where ease of use and throughput are paramount. Device architects and clinical teams must therefore balance field strength, coil design, and workflow integration against patient population needs.

Based on Application, the market is studied across Clinical Trials, Diagnostic Imaging, and Research; the Diagnostic Imaging is further studied across Cardiology, Neurology, and Oncology. Clinical trials and research environments prioritize reproducibility, standardized protocols, and quantitative endpoints, while diagnostic imaging settings demand workflow efficiency, rapid turnaround, and decision-support tools that integrate with picture archiving and communication systems. Within diagnostic imaging, cardiology applications emphasize functional and tissue characterization, neurology focuses on advanced structural and functional mapping, and oncology requires high-resolution and multiparametric assessments for staging and treatment monitoring.

Based on End User, the market is studied across Diagnostic Centers, Hospitals, Individual Radiologists, and Research Institutes, and each end user group navigates distinct procurement cycles, budget constraints, and clinical expectations. Diagnostic centers prioritize throughput and cost-effectiveness, hospitals balance specialty service lines with integrated IT investments, individual radiologists may seek portable or software-augmented tools to extend capabilities, and research institutes favor modular, extensible platforms that support novel sequences and experimental workflows. Taken together, these segmentation insights inform product roadmaps, validation priorities, and tailored commercial models that align technical capabilities with specific clinical use cases and buyer behaviors.

Region-specific dynamics and strategic implications for adoption, procurement, and partnership strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics shape adoption pathways and competitive positioning for AI-enhanced MRI solutions, driven by differences in infrastructure, reimbursement frameworks, regulatory regimes, and industrial policy. In the Americas, innovation clusters and integrated health systems create fertile environments for piloting advanced imaging applications and scaling enterprise-wide deployments; clinical adopters often emphasize outcomes-based evidence and value propositions tied to throughput and diagnostic yield. As a result, vendors commonly partner with academic centers and large hospital networks to generate multicenter clinical validation and clinician endorsement.

In Europe, Middle East & Africa, regulatory harmonization efforts and public-sector procurement mechanisms inform long procurement cycles and centralized purchasing models, while national healthcare priorities drive demand for cost-effective, energy-efficient solutions. This region also demonstrates a strong focus on data privacy, interoperability, and cross-border collaboration, which encourages federated validation approaches and standards-based integrations. Vendors navigating this region benefit from clear regulatory strategies and robust post-market surveillance frameworks that align with public payer expectations.

In Asia-Pacific, rapid capacity expansion, diverse regulatory pathways, and growing local manufacturing capabilities create a dynamic ecosystem where adoption can accelerate quickly when clinical evidence and cost profiles align. Emerging markets within the region prioritize scalable, resilient solutions that tolerate infrastructure variability and support remote diagnostics. At the same time, national initiatives to localize medical device production and increase research capacity are reshaping supply chains and creating opportunities for regional partnerships. Across all regions, geopolitical forces and trade measures further influence sourcing decisions, highlighting the importance of flexible manufacturing footprints and region-specific go-to-market approaches.

How incumbent OEMs, AI innovators, and systems integrators are differentiating through validation, partnerships, and service models to win in the evolving MRI ecosystem

Competitive dynamics in the AI-enhanced MRI space center on a mix of established imaging OEMs, emerging AI specialists, and systems integrators that bring distinct strengths to technological development and commercialization. Established device manufacturers leverage deep expertise in magnet and gradient engineering, global service networks, and existing clinical relationships to embed AI-enhanced features into next-generation platforms. These incumbents tend to focus on seamless integration, regulatory compliance across markets, and long-term service revenue models that maintain installed-base performance.

By contrast, AI specialists and software-first entrants prioritize rapid iteration, cloud-based delivery models, and clinical partnerships to validate algorithms across diverse patient cohorts. Their competitive advantage often rests on proprietary training datasets, algorithmic differentiation, and agile product development cycles. Systems integrators and value-added resellers play a critical role in assembling multi-vendor solutions that address institutional IT constraints and workflow preferences, particularly in complex hospital environments.

Successful players demonstrate several common capabilities: robust clinical validation strategies that produce peer-reviewed evidence, transparent algorithm performance reporting that supports clinician trust, and flexible commercial models that accommodate both capital procurement and subscription-based software licensing. Additionally, companies that invest in comprehensive training, local service infrastructure, and collaborative research programs tend to accelerate clinical uptake. Strategic partnerships, joint ventures, and selective acquisitions continue to be the primary mechanisms for filling capability gaps and expanding into adjacent clinical and geographic markets.

Actionable strategic recommendations for technology developers, clinical leaders, and procurement teams to accelerate adoption, manage risk, and unlock value from AI-enabled MRI innovations

Industry leaders should pursue a coordinated set of actions that align technology development, clinical validation, and commercial execution to capture value from AI-enhanced MRI innovations. First, prioritize modular architectures that decouple hardware upgrades from software and algorithmic improvements, enabling continuous feature enhancement without repeated capital expenditure. Coupled with this, establish rigorous clinical evaluation pathways that incorporate multicenter studies and peer-reviewed publication to build clinician confidence and payer recognition.

Second, strengthen supply chain resilience through supplier diversification, regional assembly capabilities, and contractual mechanisms that share tariff and logistics risks. This approach reduces deployment delays and safeguards service continuity. Third, invest in data partnerships and governance frameworks that enable federated learning, while maintaining strict privacy safeguards and traceability for model updates. These investments improve algorithm generalizability and reduce time to clinical readiness.

Fourth, adopt flexible commercial models that combine capital equipment sales with subscription-based analytics and outcome-linked service contracts to align incentives with clinical outcomes and institutional budgets. Fifth, prioritize clinician-centered design and comprehensive training programs that facilitate workflow integration, reduce cognitive load, and foster adoption. Finally, engage early with regulators and payers to clarify evidence requirements and reimbursement pathways, thereby reducing approval timelines and accelerating access to patients. Implementing these recommendations will position organizations to convert technical capabilities into sustainable clinical and commercial impact.

A rigorous mixed-methods research methodology integrating clinician interviews, regulatory analysis, patent landscaping, and evidence triangulation to inform strategic decisions and identify evidence gaps

This research synthesizes insights derived from a structured methodology that combines qualitative engagement with clinical and technical stakeholders, systematic secondary research across scientific literature and regulatory filings, and triangulation through technology and patent landscape analyses. Primary research included in-depth interviews with clinicians, radiology technologists, hospital procurement officials, systems integrators, and R&D leaders to surface real-world deployment challenges, clinical priorities, and procurement considerations. These conversations informed use-case prioritization and validation criteria for algorithm performance and service expectations.

Secondary sources encompassed peer-reviewed journals, clinical trial registries, public regulatory documents, company regulatory clearances and product specifications, and white papers from academic consortia. Patent and technology landscape analysis identified emergent architectures in reconstruction, sequence design, and AI-enabled analytics, providing insight into innovation trajectories. Data synthesis employed methodical triangulation to reconcile divergent viewpoints and to highlight consensus themes, while sensitivity checks identified areas where evidence was nascent or evolving.

Limitations of the methodology include potential sampling bias in primary interviews and the rapidly changing nature of AI model performance as new clinical evidence emerges. To mitigate these limitations, the research applied cross-validation across multiple respondent types, prioritized peer-reviewed clinical outcomes where available, and documented uncertainty where evidence remained preliminary. The result is a balanced, multidisciplinary evidence base that supports strategic decision-making while acknowledging areas for ongoing monitoring and follow-up validation.

A concise conclusion synthesizing technological, clinical, and operational imperatives that determine who succeeds in deploying AI-enabled MRI solutions at scale

In summary, AI-enhanced MRI is transitioning from demonstration projects to integrated clinical tools that improve diagnostic workflows, support quantification, and enable more patient-centric imaging protocols. Technological advances in reconstruction, algorithmic analytics, and system design are converging with shifting care delivery models to create meaningful clinical and operational benefits. At the same time, structural pressures such as trade policies, supply chain reconfiguration, and evolving regulatory expectations are shaping how solutions are designed, sourced, and deployed.

The path to sustainable value lies in aligning product architectures with clinical workflows, investing in robust multicenter validation, and building resilient supply and service networks that accommodate regional regulatory and procurement differences. Vendors and health systems that adopt modular update strategies, transparent validation practices, and collaborative partnerships will reduce friction and accelerate the translation of innovation into improved patient outcomes. Looking ahead, continuous learning systems, federated data approaches, and clinician-centered interfaces will be pivotal in ensuring that AI-enhanced MRI delivers reproducible, interpretable, and equitable diagnostic value across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. AI-Enhanced MRI System Market, by Component

  • 8.1. Hardware
    • 8.1.1. Gradient Systems
    • 8.1.2. Magnet Systems
  • 8.2. Services
    • 8.2.1. Installation Services
    • 8.2.2. Maintenance Services
  • 8.3. Software
    • 8.3.1. Data Management Solutions
    • 8.3.2. Imaging Software

9. AI-Enhanced MRI System Market, by MRI System Type

  • 9.1. Closed MRI
  • 9.2. Open MRI

10. AI-Enhanced MRI System Market, by Application

  • 10.1. Clinical Trials
  • 10.2. Diagnostic Imaging
    • 10.2.1. Cardiology
    • 10.2.2. Neurology
    • 10.2.3. Oncology
  • 10.3. Research

11. AI-Enhanced MRI System Market, by End User

  • 11.1. Diagnostic Centers
  • 11.2. Hospitals
  • 11.3. Individual Radiologists
  • 11.4. Research Institutes

12. AI-Enhanced MRI System Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. AI-Enhanced MRI System Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. AI-Enhanced MRI System Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States AI-Enhanced MRI System Market

16. China AI-Enhanced MRI System Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arterys Inc.
  • 17.6. Blackford Analysis LTD
  • 17.7. Canon Medical Systems Corporation
  • 17.8. Cerebriu A/S
  • 17.9. CityClinic Vietnam Limited
  • 17.10. CureMetrix
  • 17.11. EnvoyAI Inc.
  • 17.12. Esaote SpA
  • 17.13. Ezra AI, Inc.
  • 17.14. Fujifilm Holdings Corporation
  • 17.15. GE HealthCare Technologies Inc.
  • 17.16. HeartVista, Inc.
  • 17.17. Hitachi Medical Corporation
  • 17.18. Hyperfine, Inc.
  • 17.19. Koninklijke Philips N.V.,
  • 17.20. Medic Vision Imaging Solutions
  • 17.21. Neusoft Medical Systems
  • 17.22. Nuance Communications
  • 17.23. Perspectum Ltd
  • 17.24. Samsung Electronics Co.Ltd
  • 17.25. Siemens Healthineers AG
  • 17.26. Subtle Medical, Inc.
  • 17.27. United Imaging Healthcare Co., Ltd
  • 17.28. Volpara Solutions
  • 17.29. Zebra Medical Vision, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AI-ENHANCED MRI SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY GRADIENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY GRADIENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY GRADIENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MAGNET SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MAGNET SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MAGNET SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY INSTALLATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY INSTALLATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY INSTALLATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY IMAGING SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY IMAGING SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY IMAGING SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CLOSED MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CLOSED MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CLOSED MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY OPEN MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY OPEN MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY OPEN MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY INDIVIDUAL RADIOLOGISTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY INDIVIDUAL RADIOLOGISTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY INDIVIDUAL RADIOLOGISTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 158. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 159. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 160. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 161. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 164. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 186. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 187. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 188. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 191. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 194. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 195. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 196. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 197. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 200. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)